Literature DB >> 8735554

Absence of protein 2C from clarified foot-and-mouth disease virus vaccines provides the basis for distinguishing convalescent from vaccinated animals.

J Lubroth1, M J Grubman, T G Burrage, J F Newman, F Brown.   

Abstract

We have recently reported that cattle and pigs which have been vaccinated against foot-and-mouth disease can be distinguished from convalescent animals by the absence of antibodies to viral non-structural protein 2C (Lubroth and Brown, Res. Vet. Sci., 1995, 59, 70-78(1)). In this study, we show that the absence of 2C antibodies from the sera of vaccinated animals can be explained by the association of this viral protein with cellular debris which is separated from the virus harvest prior to inactivation of the supernatant for vaccine production. This serological marker can be of great value in countries where the disease occurs or in the veterinary regulatory arena when livestock are transported across borders, since it can be used to identify convalescent, persistently infected animals and vaccinates exposed to wild-type virus variants which have infected the vaccinated animals.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8735554     DOI: 10.1016/0264-410x(95)00172-w

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  6 in total

Review 1.  Foot-and-mouth disease.

Authors:  Marvin J Grubman; Barry Baxt
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

2.  Chemiluminescence Immunoassay for the Detection of Antibodies against the 2C and 3ABC Nonstructural Proteins Induced by Infecting Pigs with Foot-and-Mouth Disease Virus.

Authors:  Zezhong Liu; Junjun Shao; Furong Zhao; Guangqing Zhou; Shandian Gao; Wei Liu; Jianliang Lv; Xiumei Li; Yangfan Li; Huiyun Chang; Yongguang Zhang
Journal:  Clin Vaccine Immunol       Date:  2017-08-04

3.  Differentiation of foot-and-mouth disease virus-infected from vaccinated pigs by enzyme-linked immunosorbent assay using nonstructural protein 3AB as the antigen and application to an eradication program.

Authors:  Wen-Bin Chung; Karl Johan Sorensen; Pei-Chih Liao; Pin-Cheng Yang; Ming-Hwa Jong
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

4.  Epitope-resolved profiling of the SARS-CoV-2 antibody response identifies cross-reactivity with endemic human coronaviruses.

Authors:  Jason T Ladner; Sierra N Henson; Annalee S Boyle; Anna L Engelbrektson; Zane W Fink; Fatima Rahee; Jonathan D'ambrozio; Kurt E Schaecher; Mars Stone; Wenjuan Dong; Sanjeet Dadwal; Jianhua Yu; Michael A Caligiuri; Piotr Cieplak; Magnar Bjørås; Mona H Fenstad; Svein A Nordbø; Denis E Kainov; Norihito Muranaka; Mark S Chee; Sergey A Shiryaev; John A Altin
Journal:  Cell Rep Med       Date:  2021-01-19

5.  Development and Validation of Confirmatory Foot-and-Mouth Disease Virus Antibody ELISAs to Identify Infected Animals in Vaccinated Populations.

Authors:  Anuj Tewari; Helen Ambrose; Krupali Parekh; Toru Inoue; Javier Guitian; Antonello Di Nardo; David James Paton; Satya Parida
Journal:  Viruses       Date:  2021-05-15       Impact factor: 5.048

Review 6.  Biological function of Foot-and-mouth disease virus non-structural proteins and non-coding elements.

Authors:  Yuan Gao; Shi-Qi Sun; Hui-Chen Guo
Journal:  Virol J       Date:  2016-06-22       Impact factor: 4.099

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.